The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus immediately qualify for benefits. In this report, the IOM makes several recommendations for improving SSA's capacity to determine disability benefits more quickly and efficiently using the Listings.

This book discusses the benefits of application of different psychotherapy techniques, in addition to optimal medical approaches, in patients with ischemic heart disease. It explains the theoretical basis for use of these techniques, discusses the scientific evidence for their efficacy, and identifies important practical issues. Detailed attention is devoted to both well-established and recently developed approaches of proven value, as well as to future applications. In addition, practical insights are provided into the most effective ways of integrating psychotherapy with medical activities in hospitals, outpatient clinics, and rehabilitation centers. The authors are world experts in the fields of psychotherapy, pharmacology, and cardiology, who collectively provide a sound foundation for an interdisciplinary approach to patients with ischemic heart disease. Psychotherapy for Ischemic Heart Disease is both a textbook and a practical manual aimed particularly at cardiologists, psychologists, psychotherapists, and psychiatrists, but also internal medicine specialists, cardiac surgeons, general practitioners, rehabilitation doctors, students, nurses, and patients.

This book explains the pharmacological relationships between the various systems in the human body. It offers a comprehensive overview of the pharmacology concerning the autonomic, central, and peripheral nervous systems. Presenting up-to-date information on chemical mediators and their significance, it highlights the therapeutic aspects of several diseases affecting the cardiovascular, renal, respiratory, gastrointestinal, endocrinal, and hematopoietic systems. The book also includes drug therapy for microbial and neoplastic diseases. It also comprises sections on immunopharmacology, dermatological, and ocular pharmacology providing valuable insights into these emerging and recent topics. Covering the diverse groups of drugs acting on different systems, the book reviews their actions, clinical uses, adverse effects, interactions, and subcellular mechanisms of action. It is divided into 11 parts, subdivided into several chapters that evaluate the basic pharmacological principles that govern the different types of body systems. This book is intended for academicians, researchers, and clinicians in industry and academic institutions in pharmaceutical, pharmacological sciences, pharmacy, medical sciences, physiology, neurosciences, biochemistry, molecular biology and other allied health sciences.

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.

Advanced ischemic heart disease is fast becoming one of the most challenging problems facing the modern cardiovascular physician and current established therapies often fail to adequately address this population of patients. As therapy of heart disease evolves, we need to address the challenging questions posed by this clinical problem. Treatment of Advanced Ischemic Heart Disease brings together the most recent advances in surgical techniques, protection of the heart and postoperative care, to aid the study and treatment of these patients who deserve the best that modern medicine can provide them. The diagnosis and treatment of coronary artery disease and heart failure has now been standardized to the point that there are very well established guidelines promoted by the American Heart Association and The American College of Cardiology. This text will pick up where the guidelines leave off and address the real challenge of patients with advanced ischemic heart disease. Though therapy is clearly challenging, new advances are making effective therapy of these patients truly possible. This text embodies that notion. Finally, there is much still to learn about the basic mechanisms of the progression of heart failure due to coronary artery disease and how best to assess these therapeutic options. The text will address these with a focus on treatment so that it may be a practical reference for the practicing clinician as well as the basic or clinical researcher and student.

Pregnancy, childbirth, childhood, adolescence, and aging can be beset with adverse changes in psychobiology and behavior. Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging will better readers' understanding of a variety of conditions and the applicability of CBT therapy as a treatment. Featuring chapters on postnatal anxiety and depression, insomnia, and dysmorphia, the book discusses in detail the use of cognitive behavioral therapies in the treatment of these issues affecting individuals at the start and end of their lives. With expert authors from the clinical field, the book has applicability for behavioral scientists, psychologists, cognitive and behavioral neuroscientists, and anyone working to better understand and treat using cognitive behavioral therapies. - Summarizes cognitive behavioral therapies for a variety of conditions - Contains chapter abstracts, practice and procedures, application to other areas, key facts, dictionary of terms, and summary points - Covers anxiety, depression, insomnia, and autism - Includes conditions in pregnancy, childbirth, children, and adolescence

The second edition of Cognitive Therapy in Groups by Michael Free has been completely rewritten as a 25-session, structured programme of cognitive therapy in five modules. It is designed in an easy-to-present psycho-educational format that is intended for groups, but can also be used with individuals. It is sufficiently flexible for clinicians to use and adapt the resources for their own practice, and sufficiently specific to be used verbatim with a wide range of people suffering from emotional and behavioural problems. Web-based support resources include assessment tools, handouts and PowerPoint slides.